Clinical trial
Prospective, Multicenter, Single-Arm Trial Assessing Safety/Effectiveness of Multi-Branch Thoracic Stent Grafts in Aortic Arch Disease
NCT07139912 is registered in ClinicalTrials.gov with Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Single-Arm Trial Assessing Safety/Effectiveness of Multi-Branch Thoracic Stent Grafts in Aortic Arch Disease
- Lead sponsor
- Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- March 31, 2032
- Enrollment
- 96 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic arch disease